KAINOS Laboratories, Inc. (TYO:4556)

Market Cap	5.99B
Revenue (ttm)	4.44B
Net Income (ttm)	82.76M
Shares Out	4.45M
EPS (ttm)	18.58
PE Ratio	72.43
Forward PE	n/a
Dividend	32.00 (2.41%)
Ex-Dividend Date	Mar 30, 2026

Volume	2,700
Average Volume	5,260
Open	1,342.00
Previous Close	1,342.00
Day's Range	1,340.00 - 1,350.00
52-Week Range	1,035.00 - 1,404.00
Beta	0.32
RSI	64.67
Earnings Date	Jan 27, 2026

About KAINOS Laboratories

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company provides various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Tes...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1975
• Employees: 133
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4556

Financial Performance

In 2009, KAINOS Laboratories's revenue was 4.22 billion, an increase of 17.25% compared to the previous year's 3.59 billion. Earnings were 101.44 million, a decrease of -39.52%.